NOT KNOWN FACTUAL STATEMENTS ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Getting recognized the palmitoylation motif of APLNR, we designed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web page together with morphine, can inhibit the development of NCP, such as pain incidence, microglial activation, and inflamma